Clal Insurance’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

Clal Insurance’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$6.25M	Sell	13,030 -16,020	-55%	-$534K	0.03%	100
2026 Q1	$11.3M	Buy	+29,050	New	+$935K	0.07%	93
2025 Q2	–	Sell	-60,000	Closed	-$2.64M	–	216
2025 Q1	$2.64M	Buy	60,000 +44,623	+290%	+$797K	0.03%	81
2024 Q4	$4.69M	Buy	+15,377	New	+$280K	0.04%	76
2024 Q2	–	Sell	-72,500	Closed	-$11.8M	–	146
2024 Q1	$11.8M	Buy	+72,500	New	+$914K	0.13%	74
2023 Q4	–	Sell	-1,250	Closed	-$40K	–	139
2023 Q3	$40K	Buy	+1,250	New	+$11.6K	﹤0.01%	123

Other funds holding TEVA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

HIIFS

Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return

MMH

Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return

MIFH

Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

LIM

Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Clal Insurance's TEVA Position: Q2 2026 in Review

Clal Insurance increased its Teva Pharmaceutical Industries Limited (TEVA) stake by 5.6% in Q2 2026, buying an estimated $71.6M and bringing the position to 40,596,506 shares worth $1.37B. The position accounts for 6.12% of the portfolio, ranked #3.

Clal Insurance first reported a position in TEVA in Q4 2014 and has held it in 47 quarters since. 676 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

Clal Insurance held 40,596,506 shares of Teva Pharmaceutical Industries Limited worth $1.37B as of Q2 2026.
Clal Insurance bought 2,150,000 Teva Pharmaceutical Industries Limited shares in Q2 2026, an estimated $71.6M.
Teva Pharmaceutical Industries Limited made up 6.12% of Clal Insurance's portfolio in Q2 2026, its #3 holding.
Clal Insurance first reported a position in Teva Pharmaceutical Industries Limited in Q4 2014 and has held it in 47 quarters since.
676 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q2 2026.

Based on Clal Insurance's 13F filing for Q2 2026, filed 13 Aug 2026.